QSI icon

Quantum-Si Incorporated

1.15 USD
-0.01
0.86%
At close Apr 17, 4:00 PM EDT
After hours
1.14
-0.01
0.87%
1 day
-0.86%
5 days
-1.71%
1 month
-30.30%
3 months
-48.66%
6 months
47.28%
Year to date
-73.00%
1 year
-24.84%
5 years
-88.36%
10 years
-88.36%
 

About: Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Employees: 143

0
Funds holding %
of 7,407 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

216% more capital invested

Capital invested by funds: $45.8M [Q3] → $145M (+$98.9M) [Q4]

161% more call options, than puts

Call options by funds: $5.69M | Put options by funds: $2.18M

86% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 22

79% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 19

12% more funds holding

Funds holding: 106 [Q3] → 119 (+13) [Q4]

1.2% more ownership

Funds ownership: 42.46% [Q3] → 43.67% (+1.2%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$3.75
226%
upside
Avg. target
$3.75
226%
upside
High target
$3.75
226%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Alliance Global Partners
Scott Henry
0% 1-year accuracy
0 / 5 met price target
226%upside
$3.75
Buy
Initiated
7 Feb 2025

Financial journalist opinion

Based on 3 articles about QSI published over the past 30 days

Neutral
Business Wire
3 weeks ago
Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™.
Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
Neutral
Business Wire
3 weeks ago
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research.
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
Neutral
Business Wire
4 weeks ago
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research.
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
Neutral
Business Wire
1 month ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Positive
Seeking Alpha
1 month ago
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty.
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Neutral
Seeking Alpha
1 month ago
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Douglas Mcpherson - H.C. Wainright Operator Thank you for standing by.
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Quantum-Si Incorporated (QSI) Reports Q4 Loss, Lags Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.18 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.16 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q4 Loss, Lags Revenue Estimates
Neutral
Business Wire
1 month ago
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results.
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
Positive
Zacks Investment Research
1 month ago
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation.
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
Neutral
Business Wire
1 month ago
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025.
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
Charts implemented using Lightweight Charts™